(Q43272888)

English

Successful antiviral and antituberculosis treatment with pegylated interferon-alfa and ribavirin in a chronic hepatitis C patient with pulmonary tuberculosis

scientific article published in September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Successful antiviral and antituberculosis treatment with pegylated interferon-alfa and ribavirin in a chronic hepatitis C patient with pulmonary tuberculosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ming-Chao Tsai

1

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Meng-Chih Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Chao-Hung Hung

3

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

publication date

1 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Journal of the Formosan Medical Association

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

108

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

746-750

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960400-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960400-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960400-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Side effects of high-dose interferon therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960400-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A century of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960400-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between hepatitis C infection and other infectious diseases: a case for targeted screening?

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960400-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium tuberculosis in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960400-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960400-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberculosis complicating treatment of hepatitis C in an HIV-infected haemophilia A patient

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960400-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Rôle protecteur accidentel de l’interféron alpha contre mycobacterium tuberculosis au cours d’un traitement anti-viral C

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960400-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960400-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960400-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0929-6646(09)60400-9

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43272888&oldid=2139838918"